Articles On Oncosil Medical (ASX:OSL)

ASX healthcare sector gains 1.99% in November while benchmark ASX 200 down 2.66% Mach7 rises 50% in November with health imaging stock outlining a growth strategy at its AGM  Island Pharmaceuticals rises after FDA confirms Galidesivir will...

Integral Diagnostics and Medadvisor have new CEOs after the latest round of changes at the top Mayne’s refrain: let the Takeovers Panel decide It’s a case of the MEGnificent Five as Compumedics sells another brain-scanning device in China...

ASX healthcare sector fell 4.83% in October and is down more than 19% YTD CSL shares fall more than 15% on October 28 after management trims FY26 guidance Nyrada surges 165% in October on board changes and progress in phase 2a trial    Wi...

ASX lifts 0.43pc, now 2.69pc below 52-week high Materials leads gains, up 2.6pc as XGD rises 6.7pc Gains in iron ore and gold prices push resource stocks higher   ASX miners surge on gold and iron ore gains The ASX 200 rose 0.43% today, p...

 Oncosil will accelerate the rollout of its targeted radiation device after promising trial results Imricor completes ‘human factor’ ablation catheter study PYC’s CEO departure is “disappointing”, opines broker   The developer of a targe...

Ramsay says its full-year earnings met investors’ expectations – and if anything, were a tad higher Pacific Edge wins higher US reimbursement – but there’s a catch Leading up to AGMs, biotechs do the boardroom blitz   The ASX’s corporate...

ASX closes 0.52% lower as tech leads the gainers and energy leads the laggards Gold hits a new record of US$3,647 as central banks continue to stockpile the precious metal BHP agrees to pay $110 million to settle Australian class action ov...

The S&P ASX 200 Health Care index fell 13.21% in August as a tough reporting season weighed on sector CSL had its biggest ever one day fall on August 19, down 17% following softer FY25 results and restructure plans Despite the broader...

  In the medical device sector, sometimes trial news can excite investors more than the approval endgame At the application stage, devices have a much higher chance of being approved than drugs Investors can expect news from several compa...

The S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining momentum  Lumos soared 170% in July after six-year exclusive deal valued at up to US$317 million with PHASE Scientific for distribution of Febri...

 Nanosonics has launched tweaked versions of its Trophon medical probe steriliser Amplia shares soar a further 36% on pancreatic cancer promise Dimerix looks to broaden its repertoire     Nanosonics (ASX:NAN) has launched updated iteratio...

Pancreatic cancer treatment focused OncoSil Medical’s (ASX:OSL) shares stayed flat on Friday as the company revealed it had finally completed recruitment into its ‘PANCOSIL’ trial – despite first receiving ethics approval two years ago....

The ASX 200 Health Care Index fell 1.05% in June and remains the worst performing sector YTD down 6.64% Morgans healthcare analyst Iain Wilkie said June likely saw some tax loss selling before EOFY  Amplia up 300% in June after complete re...

The S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD down 5.65% Morgans healthcare analyst Iain Wilkie said US President Donald Trump’s trade and health policies continue to impact sector Lumos up...

ASX adds 52 points, hitting a new 50-day high at 8,466.70 points Broad strength with 9 of 11 sectors on the up Gold and finance stocks outperform The ASX was on a roll today, climbing swiftly in the first hour of trade and maintaining mom...

Australia’s S&P/ASX 200 rallied 4.20% in May along with global markets as US-tariff tensions eased All of 11 sectors gained in May, led by tech up almost 20% followed by energy and communication services  Dateline Resources surged 978%...

ASX slips 0.24pc in trade Falling oil prices drive energy and utilities stocks lower Gold ticks up, lifting ASX All Ords Gold Index 0.85pc   The ASX fell 0.24% during the session, experiencing broad weakness on the back of renewed tariff...

Highlights ASX 200 retreats in morning trade amid escalating US tariff actions and renewed trade tensions Dateline Resources (ASX:DTR), Firetail Resources (ASX:FTL), and DXN Limited (ASX:DXN) lead early session movements Mar...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10:15, once trading kicks off in earnes...

ASX slides 0.45pc, falling from new 50-day high Gold and resources stocks temper losses Info Tech sector leads market down   After a month of almost uninterrupted gains, the ASX has taken a dip today, shedding 0.45%. The combination of Mo...

ASX posts 0.22pc gains, recovering from dip earlier in the day Xero brings big profit and revenue gains in quarterly report, lifting stock 4.7pc Insurance Australia surges 5.7pc on Royal Automobile Club of Western Australia deal   It was...

ASX just scrapes into the green in last hour of trade, up just 0.13pc Nasdaq gains lay runway for Info Tech strength Tariff pause continues to push up oil and energy stocks After all the excitement of the last few weeks, the ASX appears t...

Medadvisor shares soar up to 60% after the company flags the sale of its Australian business Pot stock Althea sees better fortunes in the THC-infused beverage sector Clinuvel’s phase III vitiligo trial is fully recruited   With operation...

The S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Morgans healthcare analyst Iain Wilkie said April was a marked improvement on recent months Several approvals during April, including for EBR...

Energy and Tech sectors up about 1.5pc each Technology index boosted 1.26pc Materials the only laggard, down 0.59pc While a late run of bears has taken some of the wind out of the ASX’s sails, the Aussie market is firmly in the green toda...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10:15, once trading kicks off in earnes...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the top 10 data is taken at 10.15am, once trading kicks off...

Oil prices lift almost 2pc, boosting energy sector Gold reaches all-new highs of $US3,332 per ounce, pushing ASX Gold index higher Strength in rare earths lifts small cap index and materials sector   Energy and resources stocks have been...

ASX climbs 1.34pc with 10/11 sectors in the green Base metal prices recover as USD falls Gold continues strong performance, remaining near all-time highs   It’s certainly a calmer start to the week for the markets today. Strong numbers fr...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10:15, once trading kicks-off in earnes...

ASX falls 0.82pc, led down by energy and healthcare stocks Gold rises to all-time high at US$3,215 per ounce Oil falls to levels not seen since April 2020, at height of Covid-19 pandemic Despite pulling back on Tuesday, gold prices have h...

Trump’s tariffs shake markets, billions wiped off ASX Gold shines as trade war fears spark safe haven rush China, EU prep retaliation as global recession fears rise   Trump’s tariffs have hit markets hard, wiping almost $30 billion off th...

Despite a late upturn, the ASX 200 closed 0.38% in the red on Thursday Blame factor 1: Trump and his 25% US auto import tariffs, set to come into play early April Blame factor 2: A Wall Street tech rout, which Trump had a hand in, too   ...

ASX bounces back with miners leading the charge US shutdown fears ease, giving markets a lift Myer and Liontown shine as big movers on the ASX   The ASX bounced back on Friday, shaking off a three-day losing streak and finishing 0.52% hig...

ASX takes another hit, Trump’s tariffs to blame Albanese ignored by Trump ahead of tariff bombshell Retailers, miners, banks slump   Things got a bit ugly on the ASX on Wednesday with the benchmark ASX 200 index taking another big hit, th...

ASX takes a hit as energy sector sinks Gold miners shine, Star entertainment gets a lifeline Spacetalk shifts gears with AI health tech partnership   The ASX had a rough Thursday, slipping by 0.57% with the energy sector, in particular, f...

ASX dips as traders weigh China’s stimulus against Trump’s tariffs Miners soften blow but insurance stocks still taking hits Trump gives speech to Congress, here’s what he said…   The ASX had a bit of a ride on Wednesday, with a sharp dip...

The S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Morgans healthcare analyst Iain Wilkie said several factors caused investor jitters in February including job cuts to US FDA  Pacific Edge was...

ASX drops on tariff fears; BHP, Rio hit Star Entertainment Group sinks amid financial crisis Life360 shines as Endeavour tanks   It was a rough day for the ASX, dropping 1.16% as fears over new US-China tariffs sent Aussie stocks spiralli...

ASX hovers near one-month low, dragged by GYG and banks Domain soars on takeover bid RBA’s bullock admits slow rate hikes, while Alibaba rebounds   The ASX had a rough afternoon on Friday, with the market closing near its one-month low. D...

ASX closes in green after reaching new record high in morning trade Staples and tech stocks felt the love on Valentine’s Day Energy stocks and healthcare, however, got cold feet. Or the cold shoulder. Maybe both   The ASX leapt out of bed...

ASX bounces back after Trump delays tariffs Bitcoin jumps, and gold could reach US$3,000, says expert Pilbara finalises $560m deal to scoop Latin Resources   After a rough day on Monday, the ASX made a comeback today, up by 0.3% on the ba...

  Emyria says its ‘real world’ MDMA trial shows a “sustained improvement” in post-traumatic stress disorder (PTSD) symptoms Argenica says its traumatic brain injury candidate works in rats – and ferrets The biotech sector advanced to recor...

ASX near record high on inflation drop and rate cut bets Tech stocks rally as rate cut expectations rise Microsoft probes DeepSeek over data breach   The ASX200 put on a solid show today as it rose by 0.75%, closing just shy of its all-ti...

The S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024  Mesoblast surged 52% in December after the US FDA approved its cell therapy Ryoncil for treatment of paediatric GvHD Percheron plunged 91% in Dece...

ASX flat despite tech rally Uranium miners gain further after Cameco suspends production Canada’s PM Justin Trudeau set to resign amid mounting pressure   The ASX closed flattish on Monday despite a tech rally. The tech sector rose follow...

ASX closes lower on last day of 2024 Bitcoin wobbles, Aussie dollar weakens Mesoblast bucks trend with 10pc rise   It’s the last trading day of 2024, and the ASX has gone out with a whimper. After a rough start on Tuesday, the ASX closed...

ASX gives back gains ahead of Fed decision Vulcan and DigiCo rise MinRes completes $780m gas deal with Hancock Prospecting   The ASX gave back its earlier gains this afternoon as investors adopted a more cautious approach ahead of the US...

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

Harvard University’s teaching hospital will adopt Echo IQ’s AI-based aortic stenosis detection tool Immuron trots out its Travelan agenda at its AGM Oncosil goes hot and cold with latest distribution deals   Echo IQ (ASX:EIQ) has won the...